JSPR
Jasper Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
JSPR fundamentals
Jasper Therapeutics (JSPR) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.13 (YoY +8.87%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.13
+8.87%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Jasper Therapeutics (JSPR) key financial stats and ratios, covering profitability, financial health, and leverage.
Jasper Therapeutics (JSPR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Jasper Therapeutics (JSPR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Jasper Therapeutics (JSPR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Jasper Therapeutics (JSPR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Jasper Therapeutics (JSPR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Jasper Therapeutics do and what are its main business segments?What guidance did Jasper Therapeutics's management provide for the next earnings period?What were the key takeaways from Jasper Therapeutics's earnings call?What is Jasper Therapeutics's latest dividend and current dividend yield?Did Jasper Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Jasper Therapeutics next quarter?What factors drove the changes in Jasper Therapeutics's revenue and profit?What were the key takeaways from Jasper Therapeutics’s earnings call?
